These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 8950891)

  • 1. Beneficial effects of statins. GISSI-Prevenzione Investigators.
    Marchioli R; Tognoni G
    Lancet; 1996 Dec; 348(9041):1582. PubMed ID: 8950891
    [No Abstract]   [Full Text] [Related]  

  • 2. Beneficial effects of statins.
    Mikhailidis DP; Ganotatis ES; Jagroop IA; Winder AF
    Lancet; 1996 Dec; 348(9041):1582-3. PubMed ID: 8950892
    [No Abstract]   [Full Text] [Related]  

  • 3. Beneficial effects of statins.
    Rosenson RS; Tangney CC
    Lancet; 1996 Dec; 348(9041):1583. PubMed ID: 8950893
    [No Abstract]   [Full Text] [Related]  

  • 4. Statins do more than just lower cholesterol.
    Vaughan CJ; Murphy MB; Buckley BM
    Lancet; 1996 Oct; 348(9034):1079-82. PubMed ID: 8874463
    [No Abstract]   [Full Text] [Related]  

  • 5. Results of the low-dose (20 mg) pravastatin GISSI Prevenzione trial in 4271 patients with recent myocardial infarction: do stopped trials contribute to overall knowledge? GISSI Prevenzione Investigators (Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico).
    Ital Heart J; 2000 Dec; 1(12):810-20. PubMed ID: 11302109
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Statins have other beneficial properties besides their cholesterol lowering effect].
    Eriksson M
    Lakartidningen; 1998 Aug; 95(35):3670-2. PubMed ID: 9748780
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Statin-stimulated nitric oxide release from endothelium.
    Dobrucki LW; Kalinowski L; Dobrucki IT; Malinski T
    Med Sci Monit; 2001; 7(4):622-7. PubMed ID: 11433186
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of policosanol and pravastatin on lipid profile, platelet aggregation and endothelemia in older hypercholesterolemic patients.
    Castaño G; Más R; Arruzazabala ML; Noa M; Illnait J; Fernández JC; Molina V; Menéndez A
    Int J Clin Pharmacol Res; 1999; 19(4):105-16. PubMed ID: 10939028
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of simvastatin and pravastatin on endothelium-dependent relaxation in hypercholesterolemic rabbits.
    Jorge PA; Ozaki MR; Metze K
    Exp Toxicol Pathol; 1994 Dec; 46(6):465-9. PubMed ID: 7703678
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Simvastatin but not pravastatin has a direct inhibitory effect on rat and human myocyte proliferation.
    Corsini A; Raiteri M; Soma MR; Gabbiani G; Paoletti R
    Clin Biochem; 1992 Oct; 25(5):399-400. PubMed ID: 1490305
    [No Abstract]   [Full Text] [Related]  

  • 11. [Effects of atorvastatin, fluvastatin, pravastatin, and simvastatin on endothelial function, lipid peroxidation, and aortic atherosclerosis in hypercholesterolemic rabbits].
    Jorge PA; Almeida EA; Ozaki MR; Jorge M; Carneiro A
    Arq Bras Cardiol; 2005 Apr; 84(4):314-9. PubMed ID: 15880205
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Statins limit Rickettsia conorii infection in cells.
    Botelho-Nevers E; Rolain JM; Espinosa L; Raoult D
    Int J Antimicrob Agents; 2008 Oct; 32(4):344-8. PubMed ID: 18703317
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduced platelet aggregation after fluvastatin therapy is associated with altered platelet lipid composition and drug binding to the platelets.
    Osamah H; Mira R; Sorina S; Shlomo K; Michael A
    Br J Clin Pharmacol; 1997 Jul; 44(1):77-83. PubMed ID: 9241100
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Pleiotropic effects of statins].
    Mennickent C S; Bravo D M; Calvo M C; Avello L M
    Rev Med Chil; 2008 Jun; 136(6):775-82. PubMed ID: 18769836
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Can modulation of endothelial nitric oxide synthase explain the vasculoprotective actions of statins?
    Sessa WC
    Trends Mol Med; 2001 May; 7(5):189-91. PubMed ID: 11325618
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of isoprenoids in vascular smooth muscle: potential benefits of statins unrelated to cholesterol lowering.
    Hughes AD
    J Hum Hypertens; 1996 Jun; 10(6):387-90. PubMed ID: 8872802
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The mechanism of action of hypolipidemic drugs].
    Scheen AJ
    Rev Med Liege; 1997 Jun; 52(6):445-6. PubMed ID: 9289779
    [No Abstract]   [Full Text] [Related]  

  • 18. Simvastatin influences linoleic acid metabolism.
    van Doormaal JJ; Bos WJ; Muskiet FA; Doorenbos H
    Pharm Weekbl Sci; 1989 Aug; 11(4):134-5. PubMed ID: 2798037
    [No Abstract]   [Full Text] [Related]  

  • 19. [Can the action of statins reveal etiology of coronary diseases?].
    Werkö L
    Lakartidningen; 2001 Oct; 98(42):4566-7. PubMed ID: 11715228
    [No Abstract]   [Full Text] [Related]  

  • 20. The beneficial effects of HMG-coenzyme A reductase inhibitor in the primary and secondary prevention of atherosclerosis in the coronaries.
    Drown DJ
    Prog Cardiovasc Nurs; 1996; 11(2):38-9. PubMed ID: 8718962
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.